| http://www.w3.org/ns/prov#value | - Longer and more methodologically rigorous studies of anti-obesity drugs that are powered to examine endpoints such as mortality and cardiovascular morbidity are required to fully evaluate any potential benefit of such agents.PMID: 14584004 [PubMed - indexed for MEDLINE] SharePublication Types, MeSH Terms, SubstancesPublication TypesReviewMeSH TermsAnti-Obesity Agents/adverse effectsAnti-Obesity Ag
|
